Business
Hofseth BioCare ASA: Key Information Relating to Subsequent Offering
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private
About this update from Hofseth Biocare Asa
[{"type":"image","alt":"Hofseth Biocare ASA","displaySize":"","headline":null,"caption":"Hofseth Biocare ASA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":89,"url":"https://media.zenfs.com/en/globenewswire.com/e6eeab71f70356cc48046edfaa6b96f2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/d3X3Kf.TCy_ExyT_flroVQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e6eeab71f70356cc48046edfaa6b96f2","width":300,"height":89}},"lazy":false},{"type":"text","content":"NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.","length":321,"tagName":"p"},{"type":"text","content":"Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company.","length":249,"tagName":"p"},{"type":"text","content":"The board of directors has conditionally resolved to conduct a subsequent offering (the "Subsequent Offering") with gross proceeds of up to approx. NOK 30 million by issuing up to 16,666,666 new shares at NOK 1.80 per share (the "Subscription Price"), equal to the offer price in the Private Placement. The Subsequent Offering is subject to Company's extraordinary general meeting (the "EGM") authorising the Company's board of directors to issue shares in the Subsequent Offering.","length":519,"tagName":"p"},{"type":"text","content":"Please find key information relating to the Subsequent Offering below:","length":70,"tagName":"p"},{"type":"text","content":"- Date on which the terms and conditions of the repair issue were announced: 27 October 2025 - Last day including right: 24 October 2025- Ex-date: 27 October 2025- Record date: 28 October 2025- Date of approval: On or about 20 November 2025 (date of extraordinary general meeting expected to authorise the Company's board of directors to issue shares in the Subsequent Offering) - Maximum number of new shares: 16,666,666- Subscription price: NOK 1.80 per ...